EcoDrugPlus

Erb-B2 Receptor Tyrosine Kinase 3b

Ensembl ID : ENSACIG00000016571
Gene Symbol: ERBB3B
1 Cross references
207 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSACIG00000013232
Gene Symbol: ERBB4
1 Cross references
222 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4a

Ensembl ID : ENSACIG00000024060
Gene Symbol: ERBB4A
1 Cross references
243 Possible Orthologues:

Estrogen Receptor 1

Ensembl ID : ENSACIG00000007819
Gene Symbol: ESR1
1 Cross references
215 Possible Orthologues:

Estrogen Receptor 2a

Ensembl ID : ENSACIG00000008949
Gene Symbol: ESR2A
1 Cross references
200 Possible Orthologues:

Estrogen Receptor 2b

Ensembl ID : ENSACIG00000009749
Gene Symbol: ESR2B
1 Cross references
207 Possible Orthologues:

Estrogen-Related Receptor Gamma A

Ensembl ID : ENSACIG00000006202
Gene Symbol: ESRRGA
1 Cross references
203 Possible Orthologues:

Exportin 1

Ensembl ID : ENSACIG00000010818
Gene Symbol: XPO1
1 Cross references
216 Possible Orthologues:

Exportin 1

Ensembl ID : ENSACIG00000010259
Gene Symbol: XPO1
1 Cross references
228 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSACIG00000004817
Gene Symbol: FDFT1
1 Cross references
221 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSACIG00000005597
Gene Symbol: FNTA
1 Cross references
222 Possible Orthologues:

Farnesyltransferase, Caax Box, Beta

Ensembl ID : ENSACIG00000010639
Gene Symbol: FNTB
1 Cross references
203 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).